Documents & Downloads
You may order paper copies by contacting ProFunds Client Services at 866-PRO-5125 (866-776-5125)
About the Fund
Investor Class
- Ticker BIPIX
- CUSIP 743185480
- Fund Number 43
- NAV (as of 12/05/2025) $68.63
- NAV Change $0.13 ( 0.19%)
Service Class
- Ticker BIPSX
- CUSIP 743185472
- Fund Number 73
- NAV (as of 12/05/2025) $35.48
- NAV Change $0.06 (0.17%)
Details
- Inception Date 6/19/2000
- Fund Group UltraSector ProFunds
- Limits on Exchanges None
- Minimum Investment (Individual) $15,000
- Minimum Investment (Financial Professional) $5,000
- Gross Expense Ratio 1.56%
- Net Expense Ratio* 1.56%
Investor Class
- Ticker BIPIX
- CUSIP 743185480
- Fund Number 43
- NAV (as of 12/05/2025) $68.63
- NAV Change $0.13 (0.19%)
Service Class
- Ticker BIPSX
- CUSIP 743185472
- Fund Number 73
- NAV (as of 12/05/2025) $35.48
- NAV Change $0.06 (0.17%)
Details
- Inception Date 6/19/2000
- Fund Group UltraSector ProFunds
- Limits on Exchanges None
- Minimum Investment (Individual) $15,000
- Minimum Investment (Financial Professional) $5,000
- Gross Expense Ratio 1.56%
- Net Expense Ratio* 1.56%
*Contractual waiver effective from December 12024 through November 302025. Without such a waiver of feesthe total returns may have been lower.
All dataunless otherwise notedis for Investor Class Shares only and is subject to change.
Total Return
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | 18.96% | 49.20% | 32.23% | 16.84% | 13.83% | 12.08% | 7.17% | 7.58% | 1.56% | 1.56% | 06/19/2000 |
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | 17.21% | 31.02% | 11.15% | -4.95% | 12.18% | 6.16% | 6.74% | 6.87% | 1.56% | 1.56% | 06/19/2000 |
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | 18.84% | 48.79% | 31.11% | 15.64% | 12.69% | 10.96% | 6.10% | 6.52% | 2.56% | 2.56% | 06/19/2000 |
| Fund | 1m | 3m | YTD | 1Y | 3Y | 5Y | 10Y | Since Inception | Gross Expense Ratio (%) |
Net Expense Ratio |
Inception Date |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology UltraSector ProFund | 17.11% | 30.68% | 10.33% | -5.91% | 11.06% | 5.10% | 5.68% | 5.82% | 2.56% | 2.56% | 06/19/2000 |
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shareswhen redeemedmay be worth more or less than the original cost.
Index
as of 9/30/2025
- Total Number of Companies128
- Price/Earnings Ratio0
- Price/Book Ratio3.72
- Dividend Yield ( % )0.24
- Avg. Index Market Capitalization$11.93 billion
S&P Biotechnology Select Industry Index
The Index represents the biotechnology segment of the S&P Total Market Index (“S&P TMI”). The S&P TMI is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the following Global Industry Classification Standard (GICS®) sub-industry: biotechnology.
Exposures
Index as of 9/30/2025
Sum of weightings may not equal 100% due to rounding. These percentages are allowed to fluctuate between semi-annual reconstitution dates and may be higher or lower than the indicated amounts until they are reset at the next Index reconstitution date.
Distributions
There is no guarantee that dividends or interest income will be paid.